These are reasonable to explain why HES1, a regulator in the differentiation decision of hemato‐endothelial fate,45 showed minimal expression specifically in lymphocytes but was highly expressed in tumour cells, fibroblasts, and especially endothelial cells (Figure 4H). Here, HES1 is linked to neoplasm.